PTEN and gastric cancer: Therefore, it is necessary to understand the association between PTEN mutations and its expression and other biomarkers of immunotherapy in advanced GC using a large cohort and a new detection method that can cover non-hot-spot mutations and exclude nonpathogenic mutations.